Showing 2581-2590 of 8920 results for "".
Journal Club: Biologics for Young Children
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-biologics-for-young-children/32400/Practical Dermatology Editorial Board member Lawrence Eichenfield, MD, FAAD, Dawn Eichenfield, MD, PhD, discuss the article "Biologic therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations," from Expert Opinion on Drug Safety. RThe Latest in Hidradenitis Suppurativa (HS)
https://practicaldermatology.com/conferences/maui-derm-2024/the-latest-in-hidradenitis-suppurativa-hs/20251/Raj Chovatiya, MD, PhD, board-certified dermatologist and clinician investigator based in Chicago, discusses the incredible pipeline for Hidradenitis suppurativa (HS), as well as new and emerging treatment options.Winning Combinations in Scar Revision
https://practicaldermatology.com/conferences/asds-2021/winning-combinations-in-scar-revision/20028/Sherrif F. Ibrahim, MD, PhD says a combination approach is often best when it comes to laser scar revision. He discusses the devices he uses to improve the color and texture of scars to meet his patients' needs.Atopic Dermatitis: Understanding the Impact
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-understanding-the-impact/19667/For most AD patients, eczema is a bumpy ride. Even mild cases of atopic dermatitis can have a significant effect on people—and these effects range from quality of life impact to treatment costs. Peter Lio, MD describes his approach to a long-term eczema management plan.Restylane Silk Launches; Xeljanz to FDA
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-restylane-silk-launches-xeljanz-to-fda/18970/This edition of DermWireTV covers the launch of Restylane Silk from Galderma for the treatment of lips and FDA acceptance of the NDA for Pfizer's Xeljanz (tofacitinib) for adults with psoriasis. Plus, new data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) show incrJournal Club: A Comprehensive Update
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-a-comprehensive-update/32402/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the recent Lancet article "Atopic Dermatitis" with primary author Emma Guttman, MD, PhD. Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405(10478):583-596. doi: 10.1016/S0140-6736(24)0Meeting the Needs of Today's Injectables Market
https://practicaldermatology.com/series/c-suite-chats/meeting-needs-todays-injectables-market/26926/David Moatazedi, president and CEO of Evolus, talks about trends in the injectables market and the needs of younger generations.DermWireTV: The Year in Review - 2023!
https://practicaldermatology.com/topics/psoriasis/dermwiretv-the-year-in-review-2023/20229/Practical Dermatology® Co-Chief Medical Editor, Joel Schlessinger, MD, shares his thoughts on some of the best products and approvals of 2023 as well as the potential of new JAK inhibitors to treat alopecia areata, vitiligo, psoriasis, and atopic dermatitis. Our new contributor, Andrew Mastro, PA, tRecognizing Dermatologic Emergencies in Kids
https://practicaldermatology.com/conferences/scale-2023/recognizing-dermatologic-emergencies-in-kids/20198/Infections including congenital infections, syphilis, or HSV are the No. 1 cause of pediatric skin emergencies. Infantile hemangiomas in the airway can affect breathing and also require fast and early treatment, explains Thy Huynh, MD.Straight Scoop: Audience Questions Answered
https://practicaldermatology.com/topics/practice-management/straight-scoop-audience-questions-answered/19820/The panelists respond to questions from the audience about negotiating, choosing opportunities, and even how to say "No" the right way.